Relapsing Polychondritis Awareness And Support Foundation, operating under the name Relapsing Polychondritis Foundation, is located in New York, NY. The organization was established in 2014. According to its NTEE Classification (G19) the organization is classified as: Support N.E.C., under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Relapsing Polychondritis Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 03/2024, Relapsing Polychondritis Foundation generated $641.4k in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 35.2% each year . All expenses for the organization totaled $881.4k during the year ending 03/2024. While expenses have increased by 41.4% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2024
Describe the Organization's Mission:
Part 3 - Line 1
THE RP FOUNDATION'S MISSION IS TO: (A) INCREASE AWARENESS ABOUT RELAPSING POLYCHONDRITIS; (B) PROVIDE SUPPORT (PRIMARILY THROUGH THE USE OF THE INTERNET, SOCIAL MEDIA, AND PATIENT ADVOCACY PROGRAMS) FOR THOSE WHO ARE AFFECTED BY RELAPSING POLYCHONDRITIS, SUPPORT RESEARCH TO ADVANCE A CURE FOR RELAPSING POLYCHONDRITIS; (C) PROMOTE QUALITY CARE FOR RELAPSING POLYCHONDRITIS PATIENTS; AND (D) ENGAGE IN SUCH OTHER ACTIVITIES IN CONNECTION THEREWITH THAT THE BOARD OF DIRECTORS MAY AUTHORIZE, IN ALL CASES SUBJECT TO THE PROVISION OF SECTION 501(C)(3) OF THE INTERNAL REVENU CODE OF 1986, AS AMENDED, OR THE CORRESPONDING PROVISIONS OF ANY SUBSEQUENT FEDERAL TAX LAW (THE "CODE").
Describe the Organization's Program Activity:
Part 3 - Line 4a
AWARENESS: THE RELAPSING POLYCHONDRITIS FOUNDATION (RP FOUNDATION) PARTNERED WITH RACE FOR RP AND SIX INTERNATIONALLY RECOGNIZED MOTORSPORTS TEAMS TO GENERATE BRAND AWARENESS AND PROMOTE OUR PURPOSE TO THE BROADER COMMUNITY. IN 2023, THE RP FOUNDATION CREATED THE RACE OF OUR LIVES DOCUMENTARY AS A SEQUEL TO THE RIDE OF MY LIFE DOCUMENTARY THAT WAS RELEASED IN 2018. THE RACE OF OUR LIVES DOCUMENTARY CONTINUES TO INCREASE AWARENESS REGARDING RP AND HIGHLIGHTS THE DISCOVERIES AND ADVANCEMENTS THAT OUR TALENTED RESEARCH PARTNERS ARE GENERATING. THE RACE OF OUR LIVES DOCUMENTARY FEATURES A NEW MUSICAL COMPOSITION, "I WILL FIGHT," WRITTEN AND PRODUCED BY SINGER, DENISE STEFANIE. THE NEW DOCUMENTARY WON NUMEROUS AWARDS AT LOCAL FILM FESTIVALS AND WAS FEATURED IN THE APRIL / MAY EDITION OF SOUTHBAY MAGAZINE. THE RP FOUNDATION CONTINUED TO INCREASE AWARENESS AND SUPPORT FOR THE INNOVATIVE RP AND AUTOIMMUNE RESEARCH THAT WE'RE INVESTING IN VIA OUR YOUTUBE CHANNEL, ENEWSLETTER AND SOCIAL MEDIA CHANNELS (X, FACEBOOK AND INSTAGRAM).
FUNDRAISING FUNDRAISING FUELS AND DRIVES OUR RESEARCH INITIATIVES AND IS PROUD OF GUIDESTAR'S PLATINUM SEAL OF TRANSPARENCY DESIGNATION. IN FY24, THE FOUNDATION ENGAGED IN THE FOLLOWING ANNUAL, PATIENT-LED, MOTORSPORTS- TARGETED AND SALON FUNDRAISING INITIATIVES: -ANNUAL GIVING TUESDAY APPEALS -RP WARRIOR 5K WALK. PATIENTS FROM ACROSS THE US AND GLOBALLY PARTICIPATED IN THIS EVENT ORGANIZED BY RP WARRIOR, DAN SMITH, TO RAISE FUNDS TO FUEL RELAPSING POLYCHONDRITIS RESEARCH. DAN'S SON DESIGNED AND SOLD T-SHIRTS FOR THIS EVENT, WITH THE PROCEEDS DIRECTED TOWARD RP FOCUSED RESEARCH. -WATT'S THE DIFFERENCE CYCLING EVENT WAS INITIATED BY AN INDIVIDUAL IN HONOR OF HIS YOUNG NEPHEW WHO WAS DIAGNOSED WITH RP PRIOR TO HIS 9TH BIRTHDAY. THE GOAL OF THIS PATIENT-INITIATED FUNDRAISER IS TO "CHALLENGES EACH OF US TO "BE THE DIFFERENCE" FOR PATIENTS BATTLING RP. EACH PEDAL STROKE, COUPLED WITH YOUR CONTRIBUTIONS, HELPS BRING RESEARCHERS CLOSER TO SCIENTIFIC DISCOVERIES THAT WILL POTENTIALLY IMPROVE THE DIAGNOSIS AND TREATMENT OPTIONS FOR PATIENTS WITH RP - ULTIMATELY, THESE MAY LEAD TO A CURE". -2024 VIP RACE WEEKEND AT THE INDIANAPOLIS 500, HOSTED BY LONG TIME RELAPSING POLYCHONDRITIS FOUNDATION PARTNERS, KEVIN LEE AND JAMES HINCHCLIFFE, THIS EVENT RAISED FUNDS TO FUEL RP-RELATED AUTOIMMUNE DISEASE RESEARCH WHILE PROVIDING ATTENDEES WITH UNFORGETTABLE EXPERIENCES AT THE 108TH RUNNING OF THE INDIANAPOLIS 500. THIS DISTINCTIVE FUNDRAISING EVENT INCLUDED "SUITE" ACCESS TO THE LEGENDS DAY DRIVERS MEETING AND PRE-RACE REHEARSAL AS WELL AS A VIP GARAGE TOUR AND AUTOGRAPH SESSION. ADDITIONALLY, TICKETHOLDERS PARTICIPATED IN A CARB NIGHT HAPPY HOUR WITH JAMES HINCHCLIFF AND FRIENDS AT THE ROOT AND BONE IN BROAD RIPPLE, INDIANA PROCEEDS FROM THIS BENEFITED THE STOP AND GO FOUNDATION, THE RELAPSING POLYCHONDRITIS FOUNDATION AND AUTO IMMUNE DISEASE RESEARCH. -ANNUAL ERACE FOR RP: RACE FOR RP PARTNERED WITH PODIUM ESPORTS AND MONDAY NIGHT RACING FOR THE SIMULATION ERACING CHARITY EVENT. THE EVENT IS HOSTED ON THE IRACING PLATFORM AND HAS FEATURED RACES AT DAYTONA INTERNATIONAL SPEEDWAY'S ROAD COURSE AND CIRCUIT OF THE AMERICAS (COTA) IN AUSTIN, TX. THANKS TO THE GENEROSITY OF A LONG-STANDING PARTNER WHO HAS PROVIDED A 3:1 MATCH FOR GIFTS RECEIVED, THE SIM ERACE RAISES SIGNIFICANT FUNDS TO SUPPORT RP AND RELATED AUTOIMMUNE RESEARCH -DRIVING RESEARCH (2023): HOSTED BY IMSA RACECAR DRIVER, JACKSON LEE. DONORS WHO MADE A GIFT OF 100 OR MORE TO SUPPORT RP AND RELATED AUTOIMMUNE DISEASE RESEARCH WERE ABLE TO GET THEIR NAME (OR THE NAME OF WHO THEY'RE "RACING FOR") ON JACKSON'S RACECAR. AS A SPECIAL THANK YOU, ANYONE WHO DONATED WERE INVITED TO A TRACKSIDE MEET AND GREET, PROVIDED THEY ATTENDED THE RACE IN SEBRING. -KETTLEBELL FUNDRAISER: THE RP FOUNDATION WAS THE KETTLEBELL ONE HOUR LONG CYCLE INTERNATIONAL CHARITY EVENT'S FEATURED CHARITY IN 2023. -NEIL'S MILESTONE BIRTHDAY: IN LIEU OF BIRTHDAY GIFTS, GIFTS WERE DIRECTED TO THE RP FOUNDATION TO SUPPORT RP AND RELATED AUTOIMMUNE DISEASE RESEARCH. THE RP FOUNDATION IS MAKING PROGRESS IN ALL THREE PILLARS OF OUR PURPOSE, AS EVIDENCED BY THE 300% INCREASE IN THE NUMBER OF DONORS THAT THE FOUNDATION REALIZED IN 2022. LOOKING AHEAD: THE RP FOUNDATION IS INCREDIBLY THANKFUL FOR THE RP AND RELATED AUTOIMMUNE DISEASE DISCOVERIES AND ADVANCEMENTS THAT OUR TALENTED CLINICAL RESEARCH PARTNERS CONTINUE TO MAKE. WITH ADDITIONAL SUPPORT, WE WILL CONTINUE TO BE A SOURCE OF HOPE AND A CATALYST FOR RESEARCH THAT WILL ULTIMATELY TREAT AND CURE RP.
RESEARCH: WHILE RP CONTINUED TO BE A SIGNIFICANT SCIENTIFIC AND MEDICAL CHALLENGE, THE TALENTED RESEARCH PARTNERS THAT THE RP FOUNDATION INVESTED IN CONTINUED TO DRIVE RP AND RELATED AUTOIMMUNE DISEASES TO THE FOREFRONT OF GROUND- BREAKING DISCOVERIES. THE FOUNDATION CONTINUED TO SUPPORT RESEARCH CONDUCTED AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NYU GROSSMAN SCHOOL OF MEDICINE THAT IS SEARCHING FOR GENETIC MARKERS IN PATIENTS WITH RP-RELATED AUTOIMMUNE DISEASE AND BONE MARROW DISEASES. IN FY2024, THIS RESEARCH INITIATIVE ESTABLISHED A COMPREHENSIVE DATABASE OF SUBJECTS WITH BLOOD CANCERS AND AUTOIMMUNE DISEASES, INCLUDING RP. IT ALSO DEVELOPED A SCREENING PROCEDURE FOR UBA1 MUTATIONS IN PATIENTS WHO POTENTIALLY HAVE AUTOIMMUNE DISEASE. THE GOAL OF THIS RESEARCH IS TO POTENTIALLY FACILITATE THE EARLY DIAGNOSIS AND MANAGEMENT OF PATIENTS WHO HAVE THIS MUTATION. THE FOUNDATION INVESTED IN THE NEXT PHASE OF VEXAS RESEARCH BEING CONDUCTED IN THE INFLAMMATORY DISEASE GENETICS PROGRAM AT NYU LANGONE AND THE RELAPSING POLYCHONDRITIS AND AUTOINFLAMMATORY CLINICS AT THE NATIONAL INSTITUTES OF HEALTH (NIH). RESEARCHERS ADVANCED SCIENTIFIC KNOWLEDGE REGARDING THE GENETIC CHANGES ASSOCIATED WITH INFLAMMATION IN PATIENTS WITH VEXAS SYNDROME AND ESTABLISHED AN NYU VEXAS PATIENT CLINIC WITH A RHEUMATOLOGIST, WITH PLANS TO DEVELOP CLINICAL TRIALS FOR VEXAS SYNDROME AND RELATED AUTOIMMUNE DISEASES. THE RP FOUNDATION SUPPORTED PURPOSE BIOBANK AT ALLEGHENY HEALTH NETWORK WHICH LAUNCHED IN 2024 TO CREATE A CENTRALIZED, STATE-OF-THE-ART COLLECTION OF CLINICAL AND RESEARCH DATA SO RESEARCHERS CAN ADVANCE OUR COLLECTIVE UNDERSTANDING OF RELAPSING POLYCHONDRITIS AND RELATED AUTOIMMUNE DISEASES. IN FY 24, THE PENN MEDICINE RELAPSING POLYCHONDRITIS PROGRAM THAT THE RP FOUNDATION PROVIDED SEED FUNDING TO LAUNCH IS BECOMING A VALUABLE RESOURCE AND CLINICAL DESTINATION FOR PATIENTS WITH RP, WITH OVER 200 PATIENT VISITS EACH YEAR. THE PENN MEDICINE RELAPSING POLYCHONDRITIS PROGRAM GREW ITS CLINICAL ARM AS PART OF THE PENN VASCULITIS CENTER AND EXPANDED THE RESEARCH PROGRAM THROUGH THE VASCULITIS CLINICAL RESEARCH CONSORTIUM (VCRC) LONGITUDINAL STUDY OF RELAPSING POLYCHONDRITIS (RP). RESEARCHERS ANALYZED DATA FROM NEARLY 200 PATIENTS IN THE VCRC LONGITUDINAL STUDY OF RP FOCUSING ON THE CLINICAL PRESENTATIONS OF PATIENTS WITH RP AND THE MEDICATIONS USED TO TREAT THEM AND ARE GENERATING A MANUSCRIPT SUMMARIZING HER FINDINGS. ACCORDING TO PENN MEDICINE, THIS WILL BE THE LARGEST AND MOST EXTENSIVE REPORT EVER COMPILED ON RP. THE RP FOUNDATION ALSO SUPPORTED THE "FRIENDS OF PATIENTS AT NIH RP FUND" WHICH IS ADMINISTERED BY THE NIH AND PROVIDES FUNDING FOR TRAVEL AND LODGING TO ELIGIBLE PATIENTS TRAVELING TO THE NIH FOR TREATMENT.
EDUCATION: THE RP FOUNDATION AND RACE FOR RP ARE CONTINUALLY INSPIRED AND ENERGIZED BY THE COURAGE, PERSEVERANCE, AND STRENGTH OF PATIENTS LIVING WITH RP. OUR RAPIDLY EXPANDING NETWORK OF PATIENTS, DONORS, AND RESEARCHERS PROVIDES UNIQUE OPPORTUNITIES FOR IDENTIFYING, SHARING, AND DISCUSSING THE LATEST RP AND RELATED AUTOIMMUNE DISEASE DISCOVERIES. THE RP FOUNDATION SUPPORTED RP PATIENTS, ADVOCATES, AND RESEARCHERS WHO EXHIBIT AT RARE DISEASE DAY AT THE NATIONAL INSTITUTES OF HEALTH. THE EXHIBITS EMPHASIZED AWARENESS, PARTNERSHIP, AND COLLABORATION.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
David Bammert President | OfficerTrustee | 30 | $100,000 |
David Derosa Secretary/tr | OfficerTrustee | 6 | $0 |
Michael Linn Director/vic | OfficerTrustee | 8 | $0 |
Nancy Linn Director/cha | OfficerTrustee | 6 | $0 |
Francis Sweeney Director | Trustee | 6 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Jackson Lee Racing Brandambassador | 3/30/23 | $141,222 |
Ferrari North America Pub Awareness | 3/30/23 | $230,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $634,787 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $634,787 |
Total Program Service Revenue | $0 |
Investment income | $6,584 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $641,371 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $125,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $100,000 |
Compensation of current officers, directors, key employees. | $50,000 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $7,650 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $15,728 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $265,258 |
Office expenses | $1,687 |
Information technology | $18,312 |
Royalties | $0 |
Occupancy | $0 |
Travel | $35,898 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $3,475 |
All other expenses | $0 |
Total functional expenses | $881,363 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $386,620 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $386,620 |
Accounts payable and accrued expenses | $2,738 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $2,738 |
Net assets without donor restrictions | $383,882 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $386,620 |
Over the last fiscal year, Relapsing Polychondritis Awareness And Support Foundation has awarded $342,400 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
UNIVERSITY OF TEXASMD ANDERSON CANCER CENTER PURPOSE: RESEARCH | $207,400 |
FRIENDS OF PATIENTS AT THE NIHFRIENDS OF PATIENTS AT THE NIH PURPOSE: RESEARCH | $10,000 |
NYU LANGONE HEALTH PURPOSE: RESEARCH | $125,000 |